Thomas Jefferson University Comprehensive Epilepsy Center — Philadelphia, Pennsylvania

Thomas Jefferson University Comprehensive Epilepsy Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

Thomas Jefferson University Comprehensive Epilepsy Center has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Reflex Epilepsy, Photosensitive, Focal Epilepsy, Epilepsy, Complex Partial.

Sponsors: Pfizer, Xenon Pharmaceuticals Inc., Marinus Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University Comprehensive Epilepsy Center?

Thomas Jefferson University Comprehensive Epilepsy Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University Comprehensive Epilepsy Center conducted?

Thomas Jefferson University Comprehensive Epilepsy Center has 5 clinical trials on record, with 1 currently active. Their work covers Reflex Epilepsy, Photosensitive, Focal Epilepsy, Epilepsy, Complex Partial.

Is Thomas Jefferson University Comprehensive Epilepsy Center accredited by Crixeo Clinical Trials?

Thomas Jefferson University Comprehensive Epilepsy Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University Comprehensive Epilepsy Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.